Filter
Reset all

Subjects

Content Types

Countries

API

Data access

Database access

Database licenses

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 2 result(s)

Chemical composition of ancient ceramics

CRMC

Subject(s)
Content type(s)
Country
Three parts of a database provide published and unpublished chemical analysis results of archaeological ceramics. These are the results of forty years of applying WD-XRF and other mineralogical and physical laboratory methods to the analysis of sherds from excavations and museums. Drawing on some 30,000 analyses from research projects in Europe, Turkey, the near East, and Sudan, the part published here covers the results of three long-term projects: Early pottery in Thessaly, Greece (1,305 records), Firmalampen and other Roman lamps (1,666 records), and Roman and other pottery produced in Central Europe (4,043 records). This collated information provides an opportunity to work directly on published and unpublished data. These can be used as chemical reference groups for comparison for fine ware classification and in provenance studies.

ChEMBL

Subject(s)
Content type(s)
Country
ChEMBL is a database of bioactive drug-like small molecules, it contains 2-D structures, calculated properties (e.g. logP, Molecular Weight, Lipinski Parameters, etc.) and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). The data is abstracted and curated from the primary scientific literature, and cover a significant fraction of the SAR and discovery of modern drugs We attempt to normalise the bioactivities into a uniform set of end-points and units where possible, and also to tag the links between a molecular target and a published assay with a set of varying confidence levels. Additional data on clinical progress of compounds is being integrated into ChEMBL at the current time.